Login to Your Account



Biosimilars maker Walvax Biotechnology raises $73 million

By Cornelia Zou
Staff Writer

Wednesday, August 6, 2014
Walvax Biotechnology Co. Ltd. (SZ:300142) raised an additional ¥450 million (US$73 million) through a private placement. The private placement of 15 million shares will be offered to Li Yunchun, one of Walvax's major shareholders, as well as investment companies Yuxi Gaoxin Private Capital Management, Shenzhen Deruntianqing Investment Management Partnership and Yuxi Runtai Investment Management Partnership.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription